About tbcr

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Editorial Commentary 
Precision medicine for breast cancer: advances and challenges
Xin-Yi Liu, Tian-Jian Yu, Zhi-Ming Shao
Translational Breast Cancer Research  
2024;
5:
35  
Editorial Commentary 
Adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: one fits all?
Caterina Gianni, Eleonora Nicolò, Massimo Cristofanilli
Translational Breast Cancer Research  
2024;
5:
34  
Review Article 
Regulation of PI3K signaling in cancer metabolism and PI3K-targeting therapy
Beinan Han, Xiaorong Lin, Hai Hu
Translational Breast Cancer Research  
2024;
5:
33  
Review Article 
Understanding the relationship between breast cancer, immune checkpoint inhibitors, and gut microbiota: a narrative review
Gabriella Hrubesz, Jennifer Leigh, Terry L. Ng
Translational Breast Cancer Research  
2024;
5:
31  
Review Article 
Strategies for the treatment of hormone receptor-positive HER2-low breast cancer based on clinical practice: a round table discussion
Xiang Huang, Yijia Hua, Chunxiao Sun, Yongmei Yin
Translational Breast Cancer Research  
2024;
5:
30  
Review Article 
Breast ultrasound knobology and the knobology of twinkling for marker detection
Christine U. Lee, Gina K. Hesley, Taylor A. Pierson, Rebecca L. Higgins, Matthew W. Urban
Translational Breast Cancer Research  
2024;
5:
28  
Case Report 
Chemotherapy-induced neutropenia management in a patient with metastatic breast cancer and Shwachman-Diamond syndrome (SDS): a case report
Renee Morecroft, Constantine N. Logothetics, Stefan P. Tarnawsky, Andrew A. Davis
Translational Breast Cancer Research  
2024;
5:
26  
Editorial Commentary 
The optimal amino acid pattern for humans and its implications for nutrition of cancer patients
Rainer J. Klement
Translational Breast Cancer Research  
2024;
5:
25  
Editorial Commentary 
Activin A from primary breast tumors generates a pre-metastatic niche by inducing pulmonary fibrosis
Takuya Shirakihara, Akira Orimo
Translational Breast Cancer Research  
2024;
5:
24  
Editorial Commentary 
Toripalimab: a new torchlight illuminating the path for metastatic triple negative breast cancer?
Soeun Park, Sung Gwe Ahn
Translational Breast Cancer Research  
2024;
5:
23  
Editorial Commentary 
St. Gallen International Breast Cancer Conferences & Consensus
Beat Thürlimann
Translational Breast Cancer Research  
2024;
5:
22  
Review Article 
Breast cancer in pregnancy: a comprehensive review of diagnosis, management, and outcomes
Anam Mumtaz, Noor Otey, Bushra Afridi, Hazem Khout
Translational Breast Cancer Research  
2024;
5:
21  
Review Article 
A narrative review: research progress of adjuvant intensive endocrine therapy for early breast cancer
Hunan Ye, Guang Lin, Xiaojia Wang
Translational Breast Cancer Research  
2024;
5:
20  
Original Article 
Matched-pair long-term survival analysis of male and female patients with breast cancer: a population-based study
Miao Mo, Xiaoshuang Feng, Chunxiao Wu, Yangming Gong, Jie Shen, Yulian He, Changming Zhou, Zezhou Wang, Chen Fu, Ying Zheng
Translational Breast Cancer Research  
2024;
5:
19  
Clinical Practice Guideline 
Chinese Society of Clinical Oncology (CSCO) Breast Cancer guidelines 2024
Jianbin Li, Chunfang Hao, Kun Wang, Jian Zhang, Jiayi Chen, Yueping Liu, Jianyun Nie, Min Yan, Qiang Liu, Cuizhi Geng, Xiaojia Wang, Haibo Wang, Shusen Wang, Jiong Wu, Yongmei Yin, Erwei Song, Zefei Jiang
Translational Breast Cancer Research  
2024;
5:
18  
Guideline 
Chinese society of clinical oncology (CSCO) Breast Cancer Guidelines 2022
Zefei Jiang, Jianbin Li, Jiayi Chen, Yueping Liu, Kun Wang, Jianyun Nie, Xiaojia Wang, Chunfang Hao, Yongmei Yin, Shusen Wang, Min Yan, Tao Wang, Ying Yan, Xiaoyuan Chen, Erwei Song; CSCO BC guideline working group
Published online: 30 April 2022
Original Article 
Pyrotinib plus capecitabine for human epidermal factor receptor 2-positive metastatic breast cancer after trastuzumab and taxanes (PHENIX): a randomized, double-blind, placebo-controlled phase 3 study
Min Yan, Li Bian, Xichun Hu, Qingyuan Zhang, Quchang Ouyang, Jifeng Feng, Yongmei Yin, Tao Sun, Zhongsheng Tong, Xiaojia Wang, Herui Yao, Jianjun Zou, Xiaoyu Zhu, Zefei Jiang
Published online: 30 July 2020
Review Article 
Innovation drug approvals based on a bridging study: from concept to practice
Tao Wang, Xiao Cao, Yingjian He, Xiaoyuan Chen
Published online: 31 January 2022
Guideline 
Guidelines of Chinese Society of Clinical Oncology (CSCO) on Diagnosis and Treatment of Breast Cancer (2020 version)
Zefei Jiang, Erwei Song, Xiaojia Wang, Haibo Wang, Xiang Wang, Jiong Wu, Yongmei Yin, Qingyuan Zhang, Jiayi Chen, Wenyan Che, Xiaoyuan Chen, Zhanhong Chen, Peifen Fu, Cuizhi Geng, Baoliang Guo, Chunfang Hao, Yingjian He, Feng Jin, Ning Liao, Nanlin Li, Jian Liu, Qiang Liu, Yunjiang Liu, Yueping Liu, Jie Ma, Jianyun Nie, Yueyin Pan, Chuangui Song, Tao Sun, Kun Wang, Shu Wang, Tao Wang, Xin Wang, Biyun Wang, Shusen Wang, Yongsheng Wang, Ling Xu, Min Yan, Ying Yan, Peng Yuan, Junlan Yang, Fan Zhang, Jun Zhang, Shaohua Zhang, Xuan Zeng, Jianbin Li, Fengrui Xu
Published online: 31 October 2020
Guideline 
Chinese expert consensus statement on the clinical diagnosis and treatment of breast cancer bone metastasis and bone related disease
Zefei Jiang, Haibo Wang, Shu Wang, Shusen Wang, Tao Wang, Xiaojia Wang, Jifeng Feng, Jian Liu, Qiang Liu, Tao Sun, Min Yan, Qingyuan Zhang, Jiayi Chen, Quchang Ouyang, Xichun Hu, Cuizhi Geng, Peng Yuan, Yongmei Yin, Ning Liao, Yueyin Pan
Published online: 31 January 2021
Original Article 
Five-year survival in luminal breast cancer patients: relation with intratumoral activity of proteasomes
Elena E. Sereda, Elena. S. Kolegova, Gelena V. Kakurina, Dmitriy A. Korshunov, Evgenia A. Sidenko, Artem V. Doroshenko, Elena M. Slonimskaya, Irina V. Kondakova
Published online: 30 July 2022
Original Article 
Occurrence and distribution of bone metastases in 984 metastatic breast cancer patients
Huangchengyu Nie, Yang Yuan, Jianbin Li, Fengrui Xu, Tao Wang, Li Bian, Zefei Jiang, Shaohua Zhang
Published online: 31 January 2021
Original Article: Case Series 
Risk-reducing surgery in PALB2 mutations carriers with breast cancer: a case series and literature review
Monika K. Masanam, Clark W. Pitcher, Olutayo Sogunro, Leah K. Starks, Allison B. Murray, Marc E. Boisvert
Published online: 31 October 2022
Review Article 
Reprogramming of fatty acid metabolism in breast cancer: a narrative review
Jin Zhao, Fei Xie, Yang Yang, Shu Wang
Published online: 31 January 2021
Consensus 
Expert consensus on the clinical diagnosis and targeted therapy of HER2 breast cancer (2023 edition)
Jianbin Li, Xiaojia Wang, Shusen Wang, Shu Wang, Tao Wang, Yueping Liu, Cuizhi Geng, Feng Jin, Yongmei Yin, Qingyuan Zhang, Erwei Song, Jiong Wu, Zefei Jiang; Chinese Society of Clinical Oncology Breast cancer committee; Chinese Anti-Cancer Association; Committee of Breast Cancer Society
Published online: 31 October 2022
Original Article 
Analysis of the treatment patterns and safety of early breast cancer patients during the COVID-19 pandemic
Feng Li, Fengrui Xu, Huiqiang Zhang, Jianbin Li, Tao Wang, Shaohua Zhang, Li Bian, Xiaopeng Hao, Zefei Jiang
Published online: 30 July 2020
Consensus 
CSCO expert consensus on the diagnosis and treatment of breast cancer brain metastasis
Tao Wang, Jiayi Chen, Jin Yang, Minjie Fu, Wei Hua, Wang Jia, Yueping Liu, Biyun Wang, Min Yan, Juan Zhou, Chunfang Hao, Jiaxin Chen, Dan Ou, Tao Jiang, Ying Mao, Zefei Jiang; the CSCO expert panel of breast cancer
Published online: 30 July 2022
Meet the Professor 
Dr. Zefei Jiang: our journey beyond the stars and seas
Jessica Liao
Published online: 10 April 2020